Forum für Wissenschaft, Industrie und Wirtschaft

Hauptsponsoren:     3M 


Changes to DNA on-off switches affect cells' ability to repair breaks, respond to chemotherapy

Double-strand breaks in DNA happen every time a cell divides and replicates.

Depending on the type of cell, that can be pretty often. Many proteins are involved in everyday DNA repair, but if they are mutated, the repair system breaks down and cancer can occur. Cells have two complicated ways to repair these breaks, which can affect the stability of the entire genome.

Roger A. Greenberg, M.D., Ph.D., associate investigator, Abramson Family Cancer Research Institute and associate professor of Cancer Biology at the Perelman School of Medicine, University of Pennsylvania, together with postdoctoral researcher Jiangbo Tang Ph.D. and colleagues, found a key determinant in the balance between two proteins, BRCA1 and 53BP1, in the DNA repair machinery. Breast and ovarian cancer are associated with a breakdown in the repair systems involving these proteins. Their findings appear in the latest online issue of Nature Structural & Molecular Biology.

The two proteins, BRCA1 and 53BP1, control which of two cell-repair mechanisms will be used: homologous recombination or non-homologous end-joining, technically speaking. This competition has proven to be a key factor in determining whether a cell becomes cancer prone as well as how a cancer cell will respond to chemotherapy.

The key step of the balance is acetylation, the chemical process of adding a compound called an acetyl group to other cellular molecules.

The researchers asked what cell signals determine whether BRCA or 53BP1 predominates at a DNA break site.

DNA in the nucleus is tightly packed around proteins called histones. Acetylation at a specific spot on histone H4 determines the answer. If H4 is acetylated at a specific location, then 53BP1 binding near the broken DNA region is strongly reduced. This leaves BRCA1 free to do the work, kicking in the homologous recombination tool to repair the break.

On the other hand, if acetylation is reduced, 53BP1 outcompetes BRCA1 at a break and the non-homologous end-joining tool repairs the break.

This mechanism can help explain resistance to a promising chemotherapy called PARP inhibition seen in patients and mouse models with BRCA1 mutations. Work from several other research teams surprisingly has shown that if neither BRCA nor 53BP1 are available, then the homologous recombination system goes into action even in the absence of BRCA1 and BRCA1 mutant cancer cells become resistant to PARP inhibitors.

Because of this, Greenberg says, there are some possible applications for making PARP chemotherapy more sensitive: "If you could inhibit specific acetylation events, then a patient's response to PARP inhibitors might be enhanced by hyperactivating 53BP1 binding to breaks in the context of BRCA1 deficient cancers. What's more, measuring the levels of acetylation at H4 might predict how responsive an individual is to PARP inhibitors."

"The story didn't fall into place the way we thought it would," says Greenberg. "We didn't realize that it was a combination of two epigenetic marks that drives the repair system. However, we were able to show that 53BP1 doesn't bind well to regions of histone H4 that are acetylated at a specific location on H4. Collaboration with Georges Mer, a structural biologist at the Mayo Clinic, helped provide the molecular basis for these findings. We think there will be further complexity to this regulation, creating the possibility for the discovery of additional mechanisms that regulate DNA repair pathways and response to therapy and potential new targets for diagnosis and therapy."

Co-authors are Nam Woo Cho, Erica M. Manion, Niraj M. Shanbhag, all from Penn, and Gaofeng Cui, Maria Victoria Botuyan, and Georges Mer, from the Department of Biochemistry and Molecular Biology, Mayo Clinic.

The research was supported by the National Cancer Institute (1R01CA138835-01, 1R01CA132878, P50CA116201), a Research Scholar Grant from the American Cancer Society, a DOD Breast Cancer Idea Award, a UPENN-FCCC SPORE Pilot Grant, and funds from the Abramson Family Cancer Research Institute and Basser Research Center for BRCA.

Penn Medicine is one of the world's leading academic medical centers, dedicated to the related missions of medical education, biomedical research, and excellence in patient care. Penn Medicine consists of the Raymond and Ruth Perelman School of Medicine at the University of Pennsylvania (founded in 1765 as the nation's first medical school) and the University of Pennsylvania Health System, which together form a $4.3 billion enterprise.

The Perelman School of Medicine is currently ranked #2 in U.S. News & World Report's survey of research-oriented medical schools. The School is consistently among the nation's top recipients of funding from the National Institutes of Health, with $479.3 million awarded in the 2011 fiscal year.

The University of Pennsylvania Health System's patient care facilities include: The Hospital of the University of Pennsylvania -- recognized as one of the nation's top "Honor Roll" hospitals by U.S. News & World Report; Penn Presbyterian Medical Center; and Pennsylvania Hospital — the nation's first hospital, founded in 1751. Penn Medicine also includes additional patient care facilities and services throughout the Philadelphia region.

Penn Medicine is committed to improving lives and health through a variety of community-based programs and activities. In fiscal year 2011, Penn Medicine provided $854 million to benefit our community.

Karen Kreeger | EurekAlert!
Further information:

More articles from Life Sciences:

nachricht New supercomputer simulations enhance understanding of protein motion and function
24.11.2015 | DOE/Oak Ridge National Laboratory

nachricht Sensor sees nerve action as it happens
24.11.2015 | Duke University

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Follow Me: Forscher der Jacobs University steuern Unterwasser-Roboter erstmals durch Zeichensprache

Normalerweise werden Unterwasser-Roboter über lange Kabel von Booten oder von Land aus gesteuert. Forschern der Jacobs University in Bremen ist nun ein Durchbruch in der Mensch-Maschine-Kommunikation gelungen: Erstmals konnten sie einen Unterwasser-Roboter mit Hilfe von Gesten navigieren. Eine spezielle Kamera half dabei, die Zeichensprache in Befehle umzusetzen. Die Feldtests fanden im Rahmen des EU-geförderten Projektes CADDY „Cognitive Autonomous Diving buddy“ statt.

Archäologische Untersuchungen im Ozean und vergleichbare komplexe Forschungsprojekte unter Wasser sind auf die Unterstützung von Robotern angewiesen, um in...

Im Focus: Lactate for Brain Energy

Nerve cells cover their high energy demand with glucose and lactate. Scientists of the University of Zurich now provide new support for this. They show for the first time in the intact mouse brain evidence for an exchange of lactate between different brain cells. With this study they were able to confirm a 20-year old hypothesis.

In comparison to other organs, the human brain has the highest energy requirements. The supply of energy for nerve cells and the particular role of lactic acid...

Im Focus: Laser-Prozesssimulation erstmals auch als App verfügbar

Die Simulation von Prozessen bei der Lasermaterialbearbeitung ist in den letzten Jahren immer besser geworden. Die Software kann heute relativ gut voraussagen, was am Werkstück passiert. Leider ist sie hochkomplex und erfordert viel Rechenzeit. Durch eine clevere Vereinfachung können Experten vom Fraunhofer-Institut für Lasertechnik ILT erstmals eine Simulationssoftware anbieten, die Prozesse in Echtzeit rechnet und auch auf Tablets oder Smartphones läuft. Mit der schnellen Software lassen sich teure Versuche einsparen und noch besser optimale Prozessparameter finden.

Eine verlässliche Simulation von Laserprozessen war bislang eine Sache für Experten. Mit ausgefeilten Software-Paketen und viel Zeit auf Computerclustern...

Im Focus: Laser process simulation available as app for first time

In laser material processing, the simulation of processes has made great strides over the past few years. Today, the software can predict relatively well what will happen on the workpiece. Unfortunately, it is also highly complex and requires a lot of computing time. Thanks to clever simplification, experts from Fraunhofer ILT are now able to offer the first-ever simulation software that calculates processes in real time and also runs on tablet computers and smartphones. The fast software enables users to do without expensive experiments and to find optimum process parameters even more effectively.

Before now, the reliable simulation of laser processes was a job for experts. Armed with sophisticated software packages and after many hours on computer...

Im Focus: Quantensimulation: Magnetismus besser verstehen

Heidelberger Physiker imitieren mit ultrakalten Atomen das Verhalten von Elektronen in einem Festkörper

Einen neuen Ansatz zur Erforschung des Phänomens Magnetismus haben Wissenschaftler der Universität Heidelberg entwickelt. Mithilfe von ultrakalten Atomen nahe...

Alle Focus-News des Innovations-reports >>>



im innovations-report
in Kooperation mit academics

Schlafmedizin-Jahrestagung: Beginnt die Schule zu früh? Steht Deutschland zu früh auf?

24.11.2015 | Veranstaltungen

Verantwortung der Internet-Giganten – Brauchen wir eine Politik und Ethik der Algorithmen?

24.11.2015 | Veranstaltungen

Computerphysik: Experten treffen sich an Universität Leipzig

23.11.2015 | Veranstaltungen

Weitere VideoLinks >>>
Aktuelle Beiträge

Die besondere Verbindung der Produkteigenschaften von BOROFLOAT<sup>®</sup> ermöglicht dichromatische Filter und Warmlicht- oder Kaltlichtspiegel

24.11.2015 | Materialwissenschaften

Kompakte und robuste Stromversorgungen für den weltweiten Einsatz

24.11.2015 | Messenachrichten

Siemens bietet mit Digital Enterprise konkretes Lösungsportfolio für Industrie 4.0

24.11.2015 | Messenachrichten